x

Pesquisar um ensaio clínico

*(*) campo(s) de preenchimento obrigatório

354 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Baden-Württemberg
FREIBURG

Ensaio em fase de recrutamentoEnsaio a decorrerABASARC: Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis
Klinik für Pneumologie am Universitätsklinikum Freiburg
Klinik für Pneumologie

ALEMANHA

Bayern
REGENSBURG

Ensaio em fase de recrutamentoEnsaio a decorrerDer Einfluss von Timolol Nasenspray auf Epistaxis bei Morbus Osler Patienten
Universitätsklinikum Regensburg
Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde

ALEMANHA

Berlin
ADDRESS: NOT PROVIDED - DE

ALEMANHA

Berlin
BERLIN

Ensaio em fase de recrutamentoEnsaio a decorrerCONSIDER: Canakinumab for Treatment of Adult Onset Still's Disease to Achieve Reduction of Arthritic Manifestation - DE
Charité - Universitätsmedizin Berlin (CCM)
Autoinflammation Reference Center Charité (ARC²)

CANADA

Ontario
TORONTO

ESPANHA

Madrid
ADDRESS: NOT PROVIDED - ES

FRANCA

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Ensaio em fase de recrutamentoEnsaio a decorrerNOVASED: Efficiency Clinical Study of NOVATEX MEDICAL Compression Garments in Patients With Ehlers-Danlos Syndrome.
CHU de Nancy - Hôpitaux de Brabois
Service de médecine interne et immunologie clinique

PAISES BAIXOS

Utrecht
UTRECHT

Ensaio a decorrerCAPI: Conestat alfa as prophylactic treatment for idiopathic non-histaminergic acquired angioedema
UMC Utrecht - Universitair Medisch Centrum Utrecht
Laboratorium voor Translationele Immunologie

REINO UNIDO

Greater London
LONDON

Ensaio em fase de recrutamentoEnsaio a decorrerEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (ATTRIBUTE-CM)
University College London Medical School and Royal Free Hospital
National Amyloidosis Centre, Division of Medicine

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
HEIDELBERG

Ensaio a decorrerAn open-label, phase 1/2 study of melflufen and dexamethasone for patients with al amyloidosis following at least one prior line of therapy - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

FRANCA

BOURGOGNE-FRANCHE-COMTE
DIJON

Ensaio a decorrerMETOGiA: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
CHU Dijon Bourgogne - Hôpital François Mitterrand
Service de médecine interne et immunologie clinique

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio a decorrerITAC: Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Infliximab to That of Cyclophosphamide in Severe Behçet's Disease.
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Département de Médecine Interne et Immunologie Clinique (DMIIC)

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerMSC: Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells - (Phase I-II) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio a decorrerFinanciado por um membro do IRDiRCMSC-LES: Treatment of severe refractory systemic lupus erythematosus by injection of allogeneic mesenchymal stem cells derived from the umbilical cord
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité de Médecine interne, Maladies Auto-immunes et Pathologie Vasculaire

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerCHUSPAN2 : Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Churg Strauss Syndrome Without Poor Prognosis Factors (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio a decorrerPEXIVAS: Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis. An International Randomised Controlled Trial (phase III) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

NOUVELLE AQUITAINE
LIMOGES

Ensaio a decorrerAmyDara: A Multicentre Open Label Phase II Study of Daratumumab in AL Amyloidosis Patients Not in VGPR or Better - FR
CHU de Limoges - Hôpital Dupuytren
Service d'hématologie clinique et de thérapie cellulaire

ITALIA

LOMBARDIA
PAVIA

Ensaio em fase de recrutamentoEnsaio a decorrerFinanciado por um membro do IRDiRCEffect of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilatation in patients with Marfan syndrome mutation carriers of the gene FBN1
Fondazione IRCCS Policlinico San Matteo
Laboratorio di Diagnostica Molecolare, Patologia Cardiovascolare e dei Trapianti

ITALIA

TOSCANA
FIRENZE

Ensaio a decorrerRandomized Controlled Trial for Testing the Efficacy of Well-Being Therapy in Patients With Systemic Sclerosis
Università degli studi di Firenze
Dipartimento di Scienze della Salute

PAISES BAIXOS

Utrecht
UTRECHT

Ensaio a decorrerB-Vit in JIA: Modulating regulatory T cell function in JIA with Vitamin B3 (nicotinamide) treatment
UMC Utrecht - Universitair Medisch Centrum Utrecht
Kinderreumacentrum

PAISES BAIXOS

Utrecht
UTRECHT

PORTUGAL

NORTE
PORTO

Ensaio em fase de recrutamentoEnsaio a decorrerEnsaio para avaliar a segurança e tolerabilidade do ALN-TTR01 na Paramiloidose (Fase I)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

NORTE
PORTO

Ensaio a decorrerEstudo aberto de avaliação da segurança e eficácia do Fx-1006A em doentes com Amlloidose por Transtirretina (Fase II/III)
Hospital de Santo António - Centro Hospitalar do Porto
Unidade Clínica de Paramiloidose

PORTUGAL

SUL
LISBOA

Ensaio a decorrerEstudo aberto de avaliação da segurança e eficácia do Fx-1006A em doentes com Amlloidose por Transtirretina (Fase II/III)
Hospital de Sta. Maria - Centro Hospitalar de Lisboa Norte, EPE.
Serviço de Neurologia

REINO UNIDO

Cambridgeshire
CAMBRIDGE

Ensaio em fase de recrutamentoEnsaio a decorrerRituximab and Belimumab Combination Therapy in PR3 COMBIVAS
Addenbrooke's Hospital
Addenbrookes Hospital

REINO UNIDO

Greater London
LONDON

Ensaio em fase de recrutamentoEnsaio a decorrerENDURRANCE-1: Exploring durable remission with rituximab in ANCA associated vasculitis-GB
Imperial College London, main campus
Imperial College London Headquarters

REINO UNIDO

Greater Manchester
SALFORD

Ensaio a decorrerCold Challenge With C21 in RP
Salford Royal NHS Foundation Trust
University of Manchester Rheumatic Diseases Centre

SUICA

Suisse Alémanique
BERN

Ensaio em fase de recrutamentoEnsaio a decorrerGUSTO: Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab - CH
University Hospital Inselspital
Department of Rheumatology, Clinical Immunology Allergology

ALEMANHA

Baden-Württemberg
TÜBINGEN

Ensaio em fase de recrutamentoEnsaio a decorrerAST-MOMA: Highdose Chemotherapy and transplantation of CD34 selected stem cell for progressive systemic sclerosis - Modification according to manifestation (Phase II)
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

ALEMANHA

Bayern
ERLANGEN

Ensaio a decorrerRESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 3 - Rheumatologie und Immunologie

ALEMANHA

Berlin
BERLIN

Ensaio a decorrerRESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis -DE-
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

HUNGRIA

Közép-Magyarország
BUDAPEST

HUNGRIA

Közép-Magyarország
BUDAPEST

ITALIA

LIGURIA
GENOVA

Ensaio a decorrerFive-year actively controlled clinical trial in new onset juvenile dermatomyositis
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II

ITALIA

PUGLIA
BARI

Ensaio em fase de recrutamentoEnsaio a decorrerCombined Therapy With Peg-Interferon alpha, Ribavirin And Rituximab Of Hepatitis C Virus-Related Mixed Cryoglobulinemia - IT
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

PAISES BAIXOS

Groningen
GRONINGEN

REINO UNIDO

Derbyshire
CHESTERFIELD

REINO UNIDO

Greater London
LONDON

REINO UNIDO

Greater London
LONDON

Ensaio a decorrerFinanciado por um membro do IRDiRCPhase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM) - GB
UCL Institute of Neurology, University College London,
Clinical Neurosciences

REINO UNIDO

Greater London
LONDON

Ensaio a decorrerRESOLVE-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis-GB
University College London Medical School and Royal Free Hospital
Metabolic Bone Disease - Centre for Rheumatology and Connective Tissue Diseases

ALEMANHA

Baden-Württemberg
TÜBINGEN

Ensaio em fase de recrutamentoEnsaio a decorrerTOFFIFE: Tocilizumab for the Treatment of Familial Mediterranean Fever - A randomized, doubleblind, phase II proof of concept study
Interdisziplinäres Rheumazentrum (INDIRA)
Zentrum für Interdisziplinäre Rheumatologie, klinische Immunologie und Autoimmunerkrankungen

ALEMANHA

Berlin
BERLIN

ALEMANHA

Berlin
BERLIN

Ensaio em fase de recrutamentoEnsaio a decorrerTOCISCH: A Pilot Open-label Study to Assess the Efficacy and Safety of Tocilizumab in Patients With Active Schnitzler's Syndrome (Phase II)
Charité - Universitätsmedizin Berlin (CCM)
Autoinflammation Reference Center Charité (ARC²)

ESTADOS UNIDOS

New York
NEW YORK

ESTADOS UNIDOS

New York
NEW YORK

FRANCA

ILE-DE-FRANCE
PARIS

FRANCA

ILE-DE-FRANCE
PARIS

PAISES BAIXOS

Noord-Holland
AMSTERDAM

Ensaio a decorrerMicrovascular Damage in Sickle Cell Disease
Amsterdam UMC, locatie AMC
Afdeling Hematologie

Ensaio (s) clínico (s) multinacional (ais)

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

PAISES BAIXOS

Utrecht
WOERDEN